GoodRx Reports Fourth Quarter and Full Year 2023 Results

Go back to GoodRx Reports Fourth Quarter and Full Year 2023 Results

GoodRx Holdings Inc. (GDRX) PT Raised to $14 at TD Cowen, 'we remains pos.'

February 29, 2024 4:38 PM EST

TD Cowen analyst Charles Rhyee raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $14.00 (from $12.00) while maintaining a Outperform rating.

The analyst comments "We remain pos, as we continue to believe ISP oppty and its potential to drive upside to est... More